COPD and Asthma Devices Market

COPD and Asthma Devices Market Size By Product Type (Inhalers and Nebulizers), By Indication (Asthma and Chronic Obstructive Pulmonary Disease), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13599
  • Published Date: Jul, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global COPD and asthma devices market was valued at USD 50.0 billion in 2022, growing at a CAGR of 6% from 2023 to 2032. The market is expected to reach USD 89.5 billion by 2032. One of the essential factors positively influencing the market is the expanding worldwide elderly population, which is predisposed to chronic respiratory illnesses. Furthermore, rising rates of respiratory disorders induced by escalating cigarette smoking drive up sales of COPD and asthma devices. Aside from that, rising healthcare expenditures and ongoing automation in the healthcare business are driving market expansion. Manufacturers worldwide are benefiting from the widespread usage of innovative medical solutions. Healthcare practitioners and lung disease specialists currently choose a combination of a drug and a gadget due to their quick and successful results.

Market Introduction:

Chronic obstructive pulmonary disease (COPD) is an inflammatory condition that causes lung airflow to become blocked. Shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent colds, and throat pain are early indications. Asthma, often known as bronchial asthma, is a respiratory illness affecting the airways in the lungs. Shortness of breath, chest tightness, difficulty sleeping, and coughing or wheezing bouts are all signs. These respiratory disorders are treated with a variety of devices that aid in the delivery of inhaled medication. COPD and asthma devices, also known as pulmonary medication delivery devices, are used for long-term or emergency treatment of respiratory disorders. As a result, they are gaining enormous traction around the world. The key reasons driving market expansion include an increase in the prevalence of asthma and COPD, technological advancements, and an ageing population. The significant increase in the prevalence and incidence of asthma has increased the patient population, which has increased the demand for these devices. Asthma is a primary noncommunicable disease (NCD) that affects children and adults, according to the World Health Organisation (WHO) 2021 factsheet. In 2019, it afflicted an estimated 262 million individuals worldwide and killed 461,000 people. Furthermore, according to the European Respiratory Society's (ERS) research report titled "An estimate of the European prevalence of COPD in 2050," released in 2020, there were 36,580,965 Europeans with COPD.

COPD and Asthma Devices Market Size

Get an overview of this study by requesting a free sample

Recent Development

In May 2022, Alkem developed its first inhalation device, the "Innohaler," for asthma and COPD patients.

In January 2022, Life Wellness Healthcare launched a new update to its online store to ensure that COPD patients can relieve symptoms at home. The AirPhysio gadget, with flexible payment plans, is now available for delivery across the United States.

Bevespi Aerosphere (glycopyrronium/formoterol fumarate) in a pressurized metered-dose inhaler (pMDI) was approved by the European Commission (EC) in December 2018 as a maintenance dual bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

GlaxoSmithKline plc and Innoviva, Inc. received European Commission approval in November 2018 to expand a label for Trelegy Ellipta, a recognized effective exacerbation.

Market Dynamics:

Drivers

Rising Respiratory Diseases- Long-term particle air pollution exposure has been associated with higher mortality and morbidity. According to the CDC, tobacco smoke is the leading cause of COPD progression and development in the United States. However, exposure to air pollution near the workplace and home, respiratory infections, and hereditary factors all have a part. Outdoor air quality substantially impacts the progression and development of COPD in developing regions than in developed regions. COPD was the third leading cause of death among chronic lower respiratory illnesses. COPD, for example, is expected to be the third most significant cause of mortality by 2020, according to the National Health Portal.

Restraints:

Costly- COPD and asthma treatments are time-consuming and costly, and the treatment cost is a key worry because there is no one-time remedy. Because most of the asthmatic population is low-income worldwide, the high expense of therapy presents a challenge for them. For example, the American Thoracic Society estimates that the healthcare expenditures for asthma in the United States will exceed $300 billion over the next twenty years. Furthermore, the annual cost of asthma in the United States is approximately $56 billion. As a result, each year's increase in the cost of asthma treatment is predicted to stymie market growth.

Opportunities:

Rising Usage of Smart Inhalers- Smart inhalers manage breathing flow and data. The move towards more user-friendly Bluetooth-enabled smart gadgets promotes patient engagement and adherence while enhancing treatment effectiveness. In addition, next-generation inhalers are being developed with digital interfaces to manage and adapt patients' breathing patterns. These devices recognize the patient's breathing pattern and educate patients to breathe at the correct rate. This is especially important in paediatric or geriatric patients. Furthermore, medical therapies did not consistently achieve the intended purpose of curing the lungs. As a result, creating these devices aids in the specific and correct administration of medications in asthmatic patients. Because of these advantages, adopting these devices is expected to drive the growth of the COPD and asthma devices market.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global COPD and asthma devices market, with a 55% market revenue share in 2022.

Because of the increasing burden of asthma and COPD, as well as well-established healthcare infrastructure and increased awareness, the North American asthma and COPD market is expected to have a considerable proportion of the global market. According to the Canadian government, chronic obstructive pulmonary disease (COPD) impacted 453,700 and 488,100 people in 2019 and 2020, accounting for 7.2% and 7.5% of the total population, respectively. Furthermore, according to the Office of Disease Prevention and Health Promotion (ODPHP) 2020, more than 25 million people in the United States have asthma, and 14.8 million adults have COPD. According to the Asthma and Allergy Foundation of America (AAFA), 11 persons die from asthma in the United States daily. According to the same source, 4,145 individuals died from asthma in 2020. These deaths could have been avoided with appropriate treatment and care. In 2020, asthma-related mortality increased for the first time in 20 years. According to the Illinois Department of Central Management Services, the yearly direct costs per patient in the United States will exceed USD 3,000 in 2022.

In October 2019, GlaxoSmithKline plc and Innoviva, Inc. submitted a supplemental New Drug Application (SNDA) to the US Food and Drug Administration (FDA) seeking an additional indication for the use of Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol or FF/UMEC/VI), a once-daily, single-inhaler triple therapy, for the treatment of asthma in adults. Trelegy Ellipta was approved for treating Chronic Obstructive Pulmonary Disease (COPD) in the United States in September 2017.

North America Region COPD and Asthma Devices Market Share in 2022 - 55%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Type Segment Analysis

The product type segment is divided into inhalers and nebulizers. The inhalers segment dominated the market, with a share of around 55% in 2022. Inhalers are small handheld devices that deliver medications to treat chronic obstructive pulmonary disease. There are currently three types of inhalers on the market: dry powder inhalers, metered dose inhalers, and soft mist inhalers. Furthermore, inhalers are classified into two types: rescue inhalers and maintenance inhalers.

Indication Segment Analysis

The indication segment is divided into asthma and chronic obstructive pulmonary disease. The asthma segment dominated the market, with a market share of around 60% in 2022. Asthma is the most frequent chronic disease among children and is a primary noncommunicable disease (NCD) that affects both children and adults. Asthma affects more adult women than adult men in the United States. According to the Centres for Disease Control and Prevention's 2020 report, approximately 25 million Americans suffer from asthma. This equates to almost one in every thirteen Americans, including 8% of adults and 7% of children. Asthma affects around 20 million persons in the United States aged 18 and over. Furthermore, according to the Asthma and Allergy Foundation of America (AAFA), around one in every thirteen Americans, or approximately 25 million people, will have asthma in 2021. According to the same source, around 5 million American youngsters have asthma.

Some of the Key Market Players:
  • GlaxoSmithKline Plc
  • Boehringer Ingelheim International GmbH
  • 3M COMPANY
  • AstraZeneca PLC
  • PARI medical Holding GMBH
  • Novartis AG
  • GF Health Products, Inc.
  • Baxter International Inc.
  • Aerogen, Inc.
  • Smith’s Group Plc
  • Koninklijke Philips N.V. (Philips)

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 50.0 Billion
Market size value in 2032 USD 89.5 Billion
CAGR (2023 to 2032) 6%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product Type, Indication

Frequesntly Asked Questions

As per The Brainy Insights, the size of the COPD and asthma devices market was valued at USD 50.0 billion in 2022 to USD 89.5 billion by 2032.

The global COPD and asthma devices market is growing at a CAGR of 6% during the forecast period 2023-2032.

North America emerged as the largest COPD and asthma devices market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Indication
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising respiratory diseases
    5.3. Restraints
          5.3.1. Costly
    5.4. Opportunities
          5.4.1. Rising usage of smart inhalers
    5.5. Challenges
          5.5.1. Strict regulations

6. Global COPD and Asthma Devices Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Inhalers
    6.3. Nebulizers

7. Global COPD and Asthma Devices Market Analysis and Forecast, By Indication
    7.1. Segment Overview
    7.2. Asthma
    7.3. Chronic Obstructive Pulmonary Disease

8. Global COPD and Asthma Devices Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global COPD and Asthma Devices Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global COPD and Asthma Devices Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. GlaxoSmithKline Plc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Boehringer Ingelheim International GmbH
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. 3M COMPANY
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. AstraZeneca PLC
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. PARI medical Holding GMBH
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Novartis AG
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. GF Health Products, Inc.
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Baxter International Inc.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Aerogen, Inc.
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Smith’s Group Plc
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Koninklijke Philips N.V. (Philips)
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis

List of Table

1. Global COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

2. Global Inhalers, COPD and Asthma Devices Market, By Region, 2019-2032 (USD Billion) 

3. Global Nebulizers, COPD and Asthma Devices Market, By Region, 2019-2032 (USD Billion) 

4. Global COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

5. Global Asthma, COPD and Asthma Devices Market, By Region, 2019-2032 (USD Billion)

6. Global Chronic Obstructive Pulmonary Disease, COPD and Asthma Devices Market, By Region, 2019-2032 (USD Billion)

7. North America COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

8. North America COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

9. U.S. COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

10. U.S. COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

11. Canada COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

12. Canada COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

13. Mexico COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

14. Mexico COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

15. Europe COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

16. Europe COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

17. Germany COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

18. Germany COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

19. France COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

20. France COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

21. U.K. COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

22. U.K. COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

23. Italy COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

24. Italy COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

25. Spain COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

26. Spain COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

27. Asia Pacific COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

28. Asia Pacific COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

29. Japan COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

30. Japan COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

31. China COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

32. China COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

33. India COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

34. India COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

35. South America COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

36. South America COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

37. Brazil COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

38. Brazil COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

39. Middle East and Africa COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

40. Middle East and Africa COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

41. UAE COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

42. UAE COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

43. South Africa COPD and Asthma Devices Market, By Product Type, 2019-2032 (USD Billion)

44. South Africa COPD and Asthma Devices Market, By Indication, 2019-2032 (USD Billion)

List of Figures 

1. Global COPD and Asthma Devices Market Segmentation

2. Global COPD and Asthma Devices Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global COPD and Asthma Devices Market Attractiveness Analysis by Product Type

9. Global COPD and Asthma Devices Market Attractiveness Analysis by Indication

10. Global COPD and Asthma Devices Market Attractiveness Analysis by Region

11. Global COPD and Asthma Devices Market: Dynamics

12. Global COPD and Asthma Devices Market Share by Product Type (2023 & 2032)

13. Global COPD and Asthma Devices Market Share by Indication (2023 & 2032)

14. Global COPD and Asthma Devices Market Share by Regions (2023 & 2032)

15. Global COPD and Asthma Devices Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global COPD and asthma devices market based on the below-mentioned segments:

Global COPD and Asthma Devices Market By Product Type:

  • Inhalers
  • Nebulizers

Global COPD and Asthma Devices Market By Indication:

  • Asthma
  • Chronic Obstructive Pulmonary Disease 

Global COPD and Asthma Devices Market By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date